Table 1.
n | 88 |
---|---|
Age, years, median (IQR) | 10.00 (4.00) |
Range | 6–16 |
Gender: Male | 59 (67.05) |
Height, cm | 143.78 ± 16.39 |
Weight, kg | 41.76 ± 16.64 |
BMI (kg/m2) | 19.49 ± 4.51 |
Parental history of rhinitis (Y/N) | 52 (59.09) |
Parental education (>8 years) | 69 (79.31) |
Crowding Index | |
0 | 1 (1.16) |
1 | 42 (48.84) |
≥2 | 43 (50.00) |
Indoor exposure in the last 12 months* (Y/N) | 37 (42.53) |
Outdoor exposure in the last 12 months§ (Y/N) | 58 (66.67) |
ARIA classes | |
Mild Intermittent | 20 (22.73) |
Moderate-severe intermittent | 28 (31.82) |
Mild persistent | 5 (5.68) |
Moderate-severe persistent | 35 (39.77) |
Disease duration, years | 3.94 ± 3.34 |
Comorbidities ∧ | |
Allergic conjunctivitis | 15 (17.44) |
Primary snoring | 33 (37.93) |
SPT wheal size (mm), median (range)## | 4 (3–12) |
Nasal parameters | |
Log nNO, ppb | 6.76 ± 1.10 |
Nasal cytology | |
Log Eosinophils | −0.91 ± 3.08 |
Eosinophils | 4.06 ± 6.18 |
Log Neutrophils | −2.47 ± 3.50 |
Neutrophils | 7.26 ± 13.11 |
Log Mast cells | −2.64 ± 2.91 |
Mast cells | 7.28 ± 0.23 |
Nasal pH◦ | 7.28 ± 0.23 |
IL-5 pg/ml◦ | 10.43 ± 11.48 |
IL-17 pg/ml◦ | 1.44 ± 2.50 |
IL-23 pg/ml◦ | 7.08 ± 4.08 |
IFN-γ pg/ml◦ | 6.49 ± 3.64 |
Subjective measurements | |
Nasal symptoms | 3.49 ± 1.52 |
Eye symptoms | 2.51 ± 1.59 |
Practical problems | 3.26 ± 1.63 |
Activity limitation | 2.82 ± 1.38 |
Other symptoms | 2.53 ± 1.33 |
PRQLQ total score | 2.92 ± 1.28 |
Sleep disturbance | 2.33 ± 0.47 |
Sleep latency | 0.82 ± 0.90 |
Day dysfunction due to sleepiness | 0.49 ± 0.68 |
Sleep efficiency | 1.00 ± 1.31 |
Self-rated sleep quality | 0.94 ± 0.84 |
Need of medication to sleep | 0.36 ± 0.94 |
PSQI total score | 5.95 ± 2.35 |
T5SS | 8.56 ± 3.50 |
T5SS ≥6 | 64 (80.00) |
Data are presented as n (%) or as mean ± SD.
Lifetime;
Exposure to mold/pets/smoke.
Exposure to traffic at residential address.
Wheal and flare were measured, and saline-glycerin wheal size was subtracted from the grass wheal size.
Missing data n = 8.
Y/N, Yes or No; BMI, Body Mass Index; ARIA, Allergic Rhinitis and its Impact on Asthma; SPT, Skin Prick Test; nNO, nasal Nitric Oxide; PRQLQ, Pediatric Rhinoconjunctivitis Quality of Life Questionnaire; PSQI, Pittsburgh Sleep Quality Index; T5SS, Total 5 Symptom Score.